Evidence map›Paper›PMID 32655397›Full record

ReviewFrontiers in pharmacology2020

Recent Developments in Pharmacological Effect, Mechanism and Application Prospect of Diazeniumdiolates.

Bin Li, Yue Ming, Yao Liu, Haiyan Xing, Ruoqiu Fu, Ziwei Li, Rui Ni, Li Li, Dongyu Duan, Jing Xu and 4 more

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in pharmacology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
4.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 55 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Nitric oxide-releasing prodrug for the treatment of complexAntimicrobial agents and chemotherapy · 2024
    Article
  7. Article
  8. Article
  9. Article
  10. Nitric oxide suppresses cilia activity in ctenophores.bioRxiv : the preprint server for biology · 2023
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Nitric Oxide in Seed Biology.International journal of molecular sciences · 2022
    Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 1 country.

Bin LiDepartment of Pharmacy, Daping Hospital, Army Medical University, Chongqing, China.
Yue MingDepartment of Pharmacy, Daping Hospital, Army Medical University, Chongqing, China.
Yao LiuDepartment of Pharmacy, Daping Hospital, Army Medical University, Chongqing, China.
Haiyan XingDepartment of Pharmacy, Daping Hospital, Army Medical University, Chongqing, China.
Ruoqiu FuDepartment of Pharmacy, Daping Hospital, Army Medical University, Chongqing, China.
Ziwei LiDepartment of Pharmacy, Daping Hospital, Army Medical University, Chongqing, China.
Rui NiDepartment of Pharmacy, Daping Hospital, Army Medical University, Chongqing, China.
Li LiDepartment of Pharmacy, Daping Hospital, Army Medical University, Chongqing, China.
Dongyu DuanDepartment of Pharmacy, Daping Hospital, Army Medical University, Chongqing, China.
Jing XuDepartment of Pharmacy, Daping Hospital, Army Medical University, Chongqing, China.
Chen LiDepartment of Pharmacy, Daping Hospital, Army Medical University, Chongqing, China.
Mingfeng XiangDepartment of Pharmacy, Daping Hospital, Army Medical University, Chongqing, China.
Hongyu SongDepartment of Pharmacy, Daping Hospital, Army Medical University, Chongqing, China.
Jianhong ChenDepartment of Pharmacy, Daping Hospital, Army Medical University, Chongqing, China.
Army Medical University · CNDaping Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nitric oxide (NO) is a simple structured and unstable free radical molecule, which participates in the regulation of many pathophysiological processes. It functions both as a second messenger and as an endogenous neurotransmitter. Diazeniumdiolates (NONOates) are a series of compounds containing the functional parent nuclear structure of [N(O)NO]

Indexed as

application prospectcharacteristicsdiazeniumdiolatespharmacological effectstructure

Identifiers

PMID32655397
PMCPMC7324472
OpenAlexW3037594116

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.